Niche CNS Focus Small CNS clinical research site with over a decade of specialized experience in major depressive disorder, bipolar disorder, anxiety disorders, OCD, PTSD, schizophrenia, and related psychiatric indications, presenting a targeted partner for CNS trials.

Emerging Scale Potential Current staffing is lean (2-10 employees) but the established track record and portfolio across multiple psychiatric indications suggest capacity to grow with sponsor-backed expansion in early to mid-phase CNS studies.

Regional Presence Based in Oklahoma City with a focused regional footprint, offering opportunities for sponsors seeking diversified site networks outside major metro hubs to enhance patient recruitment in underrepresented markets.

Financial Footprint Revenue range indicates a monetizable collaboration history and potential for scalable partnerships; suggests openness to longer-term, cost-efficient trial management for small to mid-sized trials.

Tech and Partnerships Utilizes standard enterprise tools (Microsoft 365, Google Fonts API, hosting and web infrastructure) which can be leveraged to optimize data capture, patient engagement, and remote site support; attractive for sponsors prioritizing interoperable tech stacks and streamlined communications.